Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Business News/Market/Market Stats/Suven Life Sciences share price/ Suven Life Sciences Profit Loss Annual
Suven Life Sciences Profit & Loss Annual
Trade118.50 +1.05 (0.89%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 11.69 | 13.54 | 11.84 | 13.48 |
| Total Revenue | 11.69 | 13.54 | 11.84 | 13.48 |
| Selling/ General/ Admin Expenses Total | 18.99 | 23.25 | 27.25 | 22.07 |
| Research Development | 1,144.27 | 1,153.51 | 1,063.68 | 710.27 |
| Depreciation/ Amortization | 6.50 | 6.54 | 4.39 | 4.35 |
| Unusual Expense( Income) | -7.46 | -6.00 | -3.72 | - |
| Other Operating Expenses Total | 6.28 | - | - | - |
| Total Operating Expense | 138.74 | 139.51 | 134.45 | 97.48 |
| Operating Income | -127.05 | -125.97 | -122.61 | -84.00 |
| Interest Inc( Exp) Net- Non- Op Total | -1.58 | 75.91 | 5.81 | 58.11 |
| Other Net | 21.13 | 0.11 | 0.12 | 0.71 |
| Net Income Before Taxes | -106.08 | -118.27 | -122.00 | -77.47 |
| Provisionfor Income Taxes | -1.00 | 0.00 | 0.00 | -5.32 |
| Net Income After Taxes | -105.08 | -118.27 | -122.00 | -72.15 |
| Net Income Before Extra Items | -105.08 | -118.27 | -122.00 | -72.15 |
| Net Income | -105.08 | -118.27 | -122.00 | -72.15 |
| Income Availableto Com Excl Extra Ord | -105.08 | -118.27 | -122.00 | -72.15 |
| Income Availableto Com Incl Extra Ord | -105.08 | -118.27 | -122.00 | -72.15 |
| Diluted Net Income | -105.08 | -118.27 | -122.00 | -72.15 |
| Diluted Weighted Average Shares | 21.80 | 17.83 | 13.48 | 13.82 |
| Diluted EPS Excluding Extra Ord Items | -4.82 | -6.63 | -9.05 | -5.22 |
| Diluted Normalized EPS | -5.04 | -6.97 | -9.32 | -5.22 |
| Costof Revenue Total | - | 0.37 | 0.16 | 0.03 |
| Gross Profit | - | 13.17 | 11.68 | 13.45 |
| Gain( Loss)on Saleof Assets | - | -0.02 | -0.86 | - |
*All figures in crores except per share values
Suven Life Sciences Quick Links
Suven Life Sciences Dividend Suven Life Sciences Bonus Suven Life Sciences News Suven Life Sciences AGM Suven Life Sciences Rights Suven Life Sciences Splits Suven Life Sciences Board Meetings Suven Life Sciences Key Metrics Suven Life Sciences Shareholdings Suven Life Sciences Balance Sheet Suven Life Sciences Cashflow Suven Life Sciences Q1 Results Suven Life Sciences Q2 Results Suven Life Sciences Q3 Results Suven Life Sciences Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)